RxDoctor Payments Data

Kyle Toti, DO

Family Medicine · Cedar Hill, MONPI 1669735791

Payments from drug & device makers

$1,461in general payments, 2019–2025

Across 105 payments — averaging $13.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$67
  • Abbott$51
  • Axsome Therapeutics, Inc.$46
  • AstraZeneca$36
  • Novo Nordisk$30
  • plus $167 from 9 others

What the payments were for

  • Food & beverage$1,460100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,461 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$80,662
Medicare patients
225
Services billed
3,207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban358$192,546
Humira(Cf)Adalimumab13$104,753
XareltoRivaroxaban127$72,252
FarxigaDapagliflozin Propanediol64$69,626
JardianceEmpagliflozin136$67,054
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$57,002
MounjaroTirzepatide52$56,284
BiktarvyBictegrav/Emtricit/Tenofov Ala12$50,499
MyrbetriqMirabegron109$42,368
Breo ElliptaFluticasone/Vilanterol77$36,626
OzempicSemaglutide34$33,582
TrulicityDulaglutide26$32,964
GemtesaVibegron81$27,570
JanuviaSitagliptin Phosphate26$25,208
Semglee (Yfgn) PenInsulin Glargine-Yfgn42$23,764

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$67$192,546358 claims
AbbVieHumira(Cf), Linzess, Vraylar$1,064$138,75450 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$36$88,845112 claims
Johnson & JohnsonXarelto$17$72,252127 claims
Novo NordiskOzempic$30$33,58234 claims
Sumitomo Pharma America, Inc.Gemtesa$21$27,57081 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Cedar Hill

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →